Search

Find tools for discussing a cancer diagnosis with your children.

… Tuesday, November 26, 2019 Summary There is no easy way to tell your child that you have cancer. However, there are ways to include them in the conversation and make sure they feel supported. Being diagnosed with cancer raises all sorts of questions. And if you’re a parent, you’re likely facing one question

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.

… Tuesday, August 1, 2023 Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by  U.S. News & World Report  in its annual Best Hospitals

Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to co-opt natural wound-healing pathways. In a literal sense, metastasis is wound healing gone wrong. These findings provide a novel framework for thinking about metastasis and how to treat it.

… Monday, January 13, 2020 Bottom Line:  Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to co-opt natural wound-healing pathways. In a literal sense, metastasis is wound healing gone wrong. These findings

Jae Park, MD, a hematologic oncologist and assistant attending physician at MSK, will present findings about the durability of CAR T cell therapy response in patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) at the American Association for Cancer Research (AACR) Annual Meeting. This research has been selected to be featured in the meeting’s press program.

… Monday, April 3, 2017 Jae Park, MD , a hematologic oncologist and assistant attending physician at Memorial Sloan Kettering Cancer Center (MSK), will present findings about the durability of CAR T cell therapy response in patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) at the American

More than 10,000 people nationwide will participate in Memorial Sloan Kettering Cancer Center’s sixth annual Cycle for Survival event taking place this February at Equinox clubs in New York City, Long Island, Washington D.C., Chicago, San Francisco, and Los Angeles.

… Wednesday, February 1, 2012 More than 10,000 people nationwide will participate in Memorial Sloan Kettering Cancer Center’s sixth annual Cycle for Survival event taking place this February at Equinox clubs in New York City, Long Island, Washington D.C., Chicago, San Francisco, and Los Angeles. An indoor

Researchers discover why cancer immunotherapies often fail to finish the job.

… Monday, July 13, 2020 Summary Researchers find that changes in the metabolism of immune T cells cause them to lose their ability to attack cancer cells after initially recognizing them as a threat. Perhaps the biggest challenge facing cancer immunotherapy is figuring out why it doesn’t work for everyone

… Saturday, September 19, 2009 Twenty-four undergraduate students joined our community of scientists for ten weeks, working with faculty mentors who helped them to define and realize their research projects. The school welcomed our new class of PhD students, who have completed their first laboratory rotation

New findings from experiments done in mice suggest a surprising cause of common neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

… Wednesday, August 30, 2017 Summary Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are not well understood, and there are few effective treatments. A study from scientists at the Sloan Kettering Institute sheds light on the underlying causes of neurodegeneration and opens up new possibilities

Learn what you need to know about safety requirements for breast implants.

… Thursday, September 15, 2022 The U.S. Food and Drug Administration (FDA) reported on September 8 that a small number of cases of squamous cell carcinoma (SCC) had been found in the scar tissue of women with breast implants. The FDA is aware of fewer than 20 of these cases of SCC. While the finding appears

Early detection helps improve patient outcomes, but data shows that many cancers are going undiagnosed or untreated because of COVID-19.

… Thursday, January 28, 2021 On January 28, 2021, Memorial Sloan Kettering (MSK) and more than 75 national cancer centers and organizations endorsed an open letter from the National Comprehensive Cancer Network (NCCN) and the American Cancer Society (ACS) urging Americans to resume regular cancer screenings